Li Liman, Zhang Tiancong, Yang Chuan, Meng Qiang, Wang Shuang, Fu Yang
Department of Laboratory Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan Province, People's Republic of China.
Sichuan Clinical Research Center for Laboratory Medicine, Chengdu, Sichuan, People's Republic of China.
J Inflamm Res. 2025 May 17;18:6363-6380. doi: 10.2147/JIR.S477110. eCollection 2025.
Septic cardiomyopathy (SCM) is a prevalent complication of sepsis and a primary contributor to mortality in patients with sepsis. Although fatty acid metabolism (FAM) is known to regulate cardiac function, its specific role in the pathogenesis of SCM remains unclear.
The SCM datasets were obtained from the NCBI GEO database. Differentially expressed genes (DEGs) were subjected to GO and KEGG pathway analyses. The fatty acid metabolism-related genes were obtained from the MSigDB database. CytoHubba and machine learning algorithms identified hub FAM-DEGs. Associated transcriptional factors and miRNAs of hub FAM-DEGs were predicted using Cytoscape software and miRWalk 3.0 database. The immune infiltration pattern in SCM was analyzed using the ImmuCellAI tool. The relationship between hub FAM-DEGs and immune infiltration abundance was investigated using Spearman method. Hub FAM-DEGs expression levels were validated in clinical samples and mouse models.
Five hub FAM-DEGs associated with SCM were identified, including and . Immune analysis revealed significantly increased infiltrations of granulocytes, monocytes, M1 macrophage and neutrophils in the SCM group. Spearman analysis demonstrated that the hub FAM-DEGs were positively associated with the infiltration of pro-inflammatory immune cells. In Vivo, Down-regulations of Dhcr24 mRNA and protein levels in cardiac tissues were observed in the SCM mouse group. Clinically, the plasma concentration of DHCR24 was significantly decreased in patients with SCM.
This study revealed fatty acid metabolism played a crucial role in SCM and identified DHCR24 may act as a potential diagnostic biomarker and therapeutic target in SCM.
脓毒症性心肌病(SCM)是脓毒症常见的并发症,也是脓毒症患者死亡的主要原因。尽管已知脂肪酸代谢(FAM)可调节心脏功能,但其在SCM发病机制中的具体作用仍不清楚。
从NCBI GEO数据库获取SCM数据集。对差异表达基因(DEG)进行基因本体(GO)和京都基因与基因组百科全书(KEGG)通路分析。从MSigDB数据库获取脂肪酸代谢相关基因。利用CytoHubba和机器学习算法鉴定核心FAM-DEG。使用Cytoscape软件和miRWalk 3.0数据库预测核心FAM-DEG的相关转录因子和微小RNA(miRNA)。使用ImmuCellAI工具分析SCM中的免疫浸润模式。采用Spearman方法研究核心FAM-DEG与免疫浸润丰度之间的关系。在临床样本和小鼠模型中验证核心FAM-DEG的表达水平。
鉴定出5个与SCM相关的核心FAM-DEG,包括[具体基因1]和[具体基因2]。免疫分析显示,SCM组中粒细胞、单核细胞、M1巨噬细胞和中性粒细胞的浸润显著增加。Spearman分析表明,核心FAM-DEG与促炎免疫细胞的浸润呈正相关。在体内,SCM小鼠组心脏组织中Dhcr24 mRNA和蛋白水平下调。在临床上,SCM患者血浆中DHCR24浓度显著降低。
本研究揭示脂肪酸代谢在SCM中起关键作用,并鉴定出DHCR24可能作为SCM潜在的诊断生物标志物和治疗靶点。